Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-22-049246

Director sold 25,000 shares at $29.95 ($748,750)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Murcko Mark Director 2022-09-08 Sale −25,000 $29.95 $748,750 996,952 D
Open-market sales · 25,000 sh · avg $29.95 · $748,750
Loading xslF345X03/doc4.xml…